Skip to content

A Comparison of Sequential Compression Devices and Foot Pumps in the Obstetric Population

Study of Patient Compliance and Comfort Using Sequential Compression Devices and Foot Pumps for DVT Prevention

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00356434
Enrollment
11
Registered
2006-07-26
Start date
2008-11-30
Completion date
2009-12-31
Last updated
2017-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombophilia

Keywords

deep vein thrombosis, thrombophilia, pregnancy, thromboprophylaxis, decreased mobility, hospitalization

Brief summary

The researchers at Johns Hopkins University believe that the foot pump will be superior to sequential compression devices in comfort and patient compliance which may increase provider efforts to prevent deep vein thrombosis (DVT) in pregnancy.

Detailed description

The investigators will be comparing sequential compression devices (SCDs) to foot pumps to determine if foot pumps will be better tolerated by obstetric patients, both antepartum and intrapartum. Patients in whom thromboembolic prophylaxis is deemed necessary and ordered by the treating physician, who agree to participate in the study will be randomly assigned to receive SCDs or the foot pump as part of their thromboembolic prophylaxis regimen. The investigators will administer a questionnaire to assess patients' satisfaction and comfort with each device and they will be asked to complete a log of hours they wore their assigned device for a 7 day period (or as long as they are prescribed). Random spot checks to verify compliance will be performed.

Interventions

DEVICEKendall A-V foot impulse pump, model 6060

Will wear device for DVT prevention and receive questionnaire about compliance and comfort. Will also undergo random checks to confirm compliance with instructions and use

DEVICEKendall sequential compression device, model 9525

Will wear device for DVT prevention and receive questionnaire about compliance and comfort. Will also undergo random checks to confirm compliance with instructions and use

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant * Bedrest * Thrombophilia * Prescribed DVT prophylaxis

Exclusion criteria

* Active DVT

Design outcomes

Primary

MeasureTime frameDescription
Comfort Levelonce during first 7 days of hospitalizationScale of 1-10 (1 being very uncomfortable and 10 being very uncomfortable) describing level of comfort during the time of device use (composite score of heat, softness, discomfort).
Patient Compliancefor 1-7 days during hospitalizationNurse conducting random checks throughout hospital stay and events of noncompliance will be recorded

Secondary

MeasureTime frameDescription
DVT Preventionup to 3 monthspositive DVT on ultrasound

Countries

United States

Participant flow

Participants by arm

ArmCount
Foot Pump
Patients will have the Kendall, A-V foot impulse pump, model 6060 applied to their lower extremities to prevent DVT Kendall A-V foot impulse pump, model 6060: Will wear device for DVT prevention and receive questionnaire about compliance and comfort. Will also undergo random checks to confirm compliance with instructions and use
4
Sequential Compression Device
Patients will have the Kendall,sequential compression device, model 9525 applied to the lower extremities to prevent DVT Kendall sequential compression device, model 9525: Will wear device for DVT prevention and receive questionnaire about compliance and comfort. Will also undergo random checks to confirm compliance with instructions and use
7
Total11

Baseline characteristics

CharacteristicFoot PumpSequential Compression DeviceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
4 Participants7 Participants11 Participants
Region of Enrollment
United States
4 Participants7 Participants11 Participants
Sex: Female, Male
Female
4 Participants7 Participants11 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 40 / 7
serious
Total, serious adverse events
0 / 40 / 7

Outcome results

Primary

Comfort Level

Scale of 1-10 (1 being very uncomfortable and 10 being very uncomfortable) describing level of comfort during the time of device use (composite score of heat, softness, discomfort).

Time frame: once during first 7 days of hospitalization

ArmMeasureValue (MEAN)
Foot PumpComfort Level7 units on a scale
Sequential Compression DeviceComfort Level8 units on a scale
Primary

Patient Compliance

Nurse conducting random checks throughout hospital stay and events of noncompliance will be recorded

Time frame: for 1-7 days during hospitalization

Population: Data was not collected for this outcome measure, as the study was terminated prematurely.

Secondary

DVT Prevention

positive DVT on ultrasound

Time frame: up to 3 months

Population: Data was not collected for this outcome measure, as the study was terminated prematurely.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026